STOCK TITAN

[Form 4] Lemonade, Inc. Insider Trading Activity

Filing Impact
(High)
Filing Sentiment
(Negative)
Form Type
4
Rhea-AI Filing Summary

John Peters, Chief Insurance Officer at Lemonade, Inc. (LMND), reported multiple transactions affecting his beneficial ownership. The filing shows a charitable donation of 1,000 common shares on 08/12/2025 with no value received. On 08/13/2025 he acquired 38,155 common shares by exercising a fully vested stock option at an exercise price of $11.61 per share. The same day he sold 38,155 common shares pursuant to a Rule 10b5-1 trading plan at a sale price of $60.00 per share. Following these transactions his reported beneficial ownership is 105,115 shares.

John Peters, Chief Insurance Officer di Lemonade, Inc. (LMND), ha segnalato diverse operazioni che hanno interessato la sua titolarità effettiva. La comunicazione indica una donazione a fini benefici di 1.000 azioni ordinarie l'08/12/2025 senza ricevere alcun corrispettivo. Il 13/08/2025 ha acquisito 38.155 azioni ordinarie esercitando un'opzione su azioni completamente maturata al prezzo di esercizio di $11,61 per azione. Nello stesso giorno ha venduto 38.155 azioni ordinarie ai sensi di un piano di negoziazione Rule 10b5-1 al prezzo di vendita di $60,00 per azione. Dopo queste operazioni la sua titolarità effettiva riportata è di 105.115 azioni.

John Peters, Chief Insurance Officer de Lemonade, Inc. (LMND), informó varias transacciones que afectan su propiedad beneficiaria. El informe muestra una donación benéfica de 1.000 acciones ordinarias el 12/08/2025 sin recibir contraprestación. El 13/08/2025 adquirió 38.155 acciones ordinarias ejerciendo una opción sobre acciones totalmente consolidada a un precio de ejercicio de $11,61 por acción. Ese mismo día vendió 38.155 acciones ordinarias conforme a un plan de negociación Rule 10b5-1 a un precio de venta de $60,00 por acción. Tras estas operaciones, su propiedad beneficiaria reportada es de 105.115 acciones.

레모네이드(Lemonade, Inc., LMND)의 최고보험책임자(Chief Insurance Officer) 존 피터스(John Peters)가 그의 실질 소유권에 영향을 미친 여러 거래를 보고했습니다. 제출 서류에는 2025-08-12에 대가 없이 기부된 1,000주 보통주가 기재되어 있습니다. 2025-08-13에 그는 완전 취득된 스톡옵션을 행사하여 주당 $11.61의 행사가격으로 38,155주 보통주를 취득했습니다. 같은 날 그는 Rule 10b5-1 거래계획에 따라 주당 $60.0038,155주 보통주를 매도했습니다. 이들 거래 후 보고된 그의 실질 소유주식수는 105,115주입니다.

John Peters, Chief Insurance Officer chez Lemonade, Inc. (LMND), a déclaré plusieurs opérations affectant sa propriété bénéficiaire. Le dépôt indique un don caritatif de 1 000 actions ordinaires le 12/08/2025 sans contrepartie reçue. Le 13/08/2025, il a acquis 38 155 actions ordinaires en exerçant une option d'achat d'actions totalement acquise au prix d'exercice de 11,61 $ par action. Le même jour, il a vendu 38 155 actions ordinaires en vertu d'un plan de négociation Rule 10b5-1 au prix de vente de 60,00 $ par action. À l'issue de ces opérations, sa détention bénéficiaire déclarée est de 105 115 actions.

John Peters, Chief Insurance Officer bei Lemonade, Inc. (LMND), meldete mehrere Transaktionen, die sein wirtschaftliches Eigentum betreffen. Die Meldung weist eine wohltätige Schenkung von 1.000 Stammaktien am 12.08.2025 ohne Gegenleistung aus. Am 13.08.2025 erwarb er durch Ausübung einer vollständig vested Aktienoption 38.155 Stammaktien zum Ausübungspreis von $11,61 pro Aktie. Am gleichen Tag verkaufte er gemäß einem Rule-10b5-1-Handelsplan 38.155 Stammaktien zu einem Verkaufspreis von $60,00 pro Aktie. Nach diesen Transaktionen beträgt sein gemeldetes wirtschaftliches Eigentum 105.115 Aktien.

Positive
  • Fully vested option exercise disclosed for 38,155 shares at an $11.61 exercise price, providing clear reporting of option status
  • Sale executed under a Rule 10b5-1 plan, indicating the sale was prearranged and compliant with trading-plan safeguards
  • Charitable donation disclosed of 1,000 shares with no value received, reflecting transparent reporting of gifts
Negative
  • Substantial sale of 38,155 shares at $60.00 reduced the reporting person\'s holdings to 105,115 shares
  • No commentary provided on intent or impact of the sale beyond the 10b5-1 designation, limiting interpretability for investors

Insights

TL;DR Insider exercised vested options, sold the same number of shares under a 10b5-1 plan, and made a small charitable donation.

The filing documents routine insider activity: a fully vested option exercise for 38,155 shares at $11.61 and an immediate sale of 38,155 shares at $60.00 under a Rule 10b5-1 plan on 08/13/2025. The exercise increased gross share holdings briefly but the concurrent sale left the reporting person with 105,115 shares beneficially owned. A separate donation of 1,000 shares on 08/12/2025 is disclosed with no value received. These are transaction-level disclosures without forward-looking commentary or changes to their role.

TL;DR Disclosed actions align with standard insider reporting: vested option exercise, planned sale, and charitable gift.

The Form 4 indicates compliance with disclosure rules: the option was noted as fully vested, the sale was executed pursuant to a Rule 10b5-1 trading plan, and a gift of 1,000 shares is explicitly labeled charitable. The record is signed by an attorney-in-fact and includes transaction codes and prices, providing clear auditability. There are no disclosures of additional derivative holdings beyond the exercised option converting to 38,155 common shares.

John Peters, Chief Insurance Officer di Lemonade, Inc. (LMND), ha segnalato diverse operazioni che hanno interessato la sua titolarità effettiva. La comunicazione indica una donazione a fini benefici di 1.000 azioni ordinarie l'08/12/2025 senza ricevere alcun corrispettivo. Il 13/08/2025 ha acquisito 38.155 azioni ordinarie esercitando un'opzione su azioni completamente maturata al prezzo di esercizio di $11,61 per azione. Nello stesso giorno ha venduto 38.155 azioni ordinarie ai sensi di un piano di negoziazione Rule 10b5-1 al prezzo di vendita di $60,00 per azione. Dopo queste operazioni la sua titolarità effettiva riportata è di 105.115 azioni.

John Peters, Chief Insurance Officer de Lemonade, Inc. (LMND), informó varias transacciones que afectan su propiedad beneficiaria. El informe muestra una donación benéfica de 1.000 acciones ordinarias el 12/08/2025 sin recibir contraprestación. El 13/08/2025 adquirió 38.155 acciones ordinarias ejerciendo una opción sobre acciones totalmente consolidada a un precio de ejercicio de $11,61 por acción. Ese mismo día vendió 38.155 acciones ordinarias conforme a un plan de negociación Rule 10b5-1 a un precio de venta de $60,00 por acción. Tras estas operaciones, su propiedad beneficiaria reportada es de 105.115 acciones.

레모네이드(Lemonade, Inc., LMND)의 최고보험책임자(Chief Insurance Officer) 존 피터스(John Peters)가 그의 실질 소유권에 영향을 미친 여러 거래를 보고했습니다. 제출 서류에는 2025-08-12에 대가 없이 기부된 1,000주 보통주가 기재되어 있습니다. 2025-08-13에 그는 완전 취득된 스톡옵션을 행사하여 주당 $11.61의 행사가격으로 38,155주 보통주를 취득했습니다. 같은 날 그는 Rule 10b5-1 거래계획에 따라 주당 $60.0038,155주 보통주를 매도했습니다. 이들 거래 후 보고된 그의 실질 소유주식수는 105,115주입니다.

John Peters, Chief Insurance Officer chez Lemonade, Inc. (LMND), a déclaré plusieurs opérations affectant sa propriété bénéficiaire. Le dépôt indique un don caritatif de 1 000 actions ordinaires le 12/08/2025 sans contrepartie reçue. Le 13/08/2025, il a acquis 38 155 actions ordinaires en exerçant une option d'achat d'actions totalement acquise au prix d'exercice de 11,61 $ par action. Le même jour, il a vendu 38 155 actions ordinaires en vertu d'un plan de négociation Rule 10b5-1 au prix de vente de 60,00 $ par action. À l'issue de ces opérations, sa détention bénéficiaire déclarée est de 105 115 actions.

John Peters, Chief Insurance Officer bei Lemonade, Inc. (LMND), meldete mehrere Transaktionen, die sein wirtschaftliches Eigentum betreffen. Die Meldung weist eine wohltätige Schenkung von 1.000 Stammaktien am 12.08.2025 ohne Gegenleistung aus. Am 13.08.2025 erwarb er durch Ausübung einer vollständig vested Aktienoption 38.155 Stammaktien zum Ausübungspreis von $11,61 pro Aktie. Am gleichen Tag verkaufte er gemäß einem Rule-10b5-1-Handelsplan 38.155 Stammaktien zu einem Verkaufspreis von $60,00 pro Aktie. Nach diesen Transaktionen beträgt sein gemeldetes wirtschaftliches Eigentum 105.115 Aktien.

SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Peters John Sheldon

(Last) (First) (Middle)
C/O LEMONADE, INC.
5 CROSBY STREET, 3RD FLOOR

(Street)
NEW YORK NY 10013

(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
Lemonade, Inc. [ LMND ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director 10% Owner
X Officer (give title below) Other (specify below)
Chief Insurance Officer
3. Date of Earliest Transaction (Month/Day/Year)
08/13/2025
4. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
COMMON STOCK 08/12/2025 G(1) V 1,000 D $0 105,115 D
COMMON STOCK 08/13/2025 M 38,155 A $11.61 143,270 D
COMMON STOCK 08/13/2025 S(2) 38,155 D $60 105,115 D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
STOCK OPTION $11.61 08/13/2025 M 38,155 (3) 02/05/2029 COMMON STOCK 38,155 $11.61 11,845 D
Explanation of Responses:
1. This transaction represents a charitable donation to a third party. No value was received for the gifted shares.
2. Represents sale pursuant to a Rule 10b5-1 trading plan.
3. The stock option is fully vested.
Remarks:
/s/ Timothy Bixby, Attorney-in-Fact for John Peters 08/15/2025
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What transactions did John Peters (LMND) report on the Form 4?

He donated 1,000 shares on 08/12/2025, exercised a fully vested option for 38,155 shares at $11.61 on 08/13/2025, and sold 38,155 shares at $60.00 on 08/13/2025.

How many shares does John Peters beneficially own after these transactions?

105,115 shares beneficially owned following the reported transactions.

Was the sale of shares by John Peters part of a prearranged trading plan?

Yes, the sale of 38,155 shares on 08/13/2025 is reported as executed pursuant to a Rule 10b5-1 trading plan.

What was the exercise price and sale price reported?

Exercise price: $11.61 per share; Sale price: $60.00 per share.

Is there any indication the stock option was vested?

Yes, the filer states the stock option is fully vested.
Lemonade Inc

NYSE:LMND

LMND Rankings

LMND Latest News

LMND Latest SEC Filings

LMND Stock Data

4.12B
59.16M
18.37%
53.63%
23.97%
Insurance - Property & Casualty
Fire, Marine & Casualty Insurance
Link
United States
NEW YORK